The controversial point of treatment for oropharyngeal cancer is the surgical approach
and it is in transition, especially for resectable tumors. Transcervical oropharyngectomy
with mandibulotomy is an oncologically valid surgical option for resectable T3–T4a
oropharyngeal cancers and contraindications for transoral lateral oropharyngectomy. The
approach without mandibulotomy allows for simple reconstruction and has a low complication
rate. In particular, it spares the patients’ morbidity related to mandibulotomy.
The transoral approach, especially with robotic surgical systems seem likely to offer an alternative
approach and refinement of oropharuyngectomy in the future.